Skin cancer detector concept wins global design prize
A group of Canadians has developed an early prototype of a cheap, handheld scanner that could one day help doctors painlessly diagnose skin cancer in their offices. The team of…
Ford’s cancer not responding to latest chemotherapy
Rob Ford, 46, was diagnosed with an aggressive form of cancer called liposarcoma after a tumour was discovered in his abdomen in the fall of 2014. To read more http://www.cbc.ca/news/1.3498155……
Merck’s Keytruda helps lung cancer patients live longer in trial
(Reuters) – Merck & Co’s (MRK.N) blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its position as the dominant player in…
Lilly’s Cyramza succeeds in late-stage liver cancer trial
(Reuters) – Eli Lilly and Co on Wednesday said its drug Cyramza met the main goal of helping patients live longer in a late-stage trial, which tested it as a…
Pfizer signs deal with Allogene to develop cancer cell therapy
(Reuters) – Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake,…
Starbucks coffee in California must have cancer warning, judge says
(Reuters) – Starbucks Corp (SBUX.O) and other coffee sellers must put a cancer warning on coffee sold in California, a Los Angeles judge has ruled, possibly exposing the companies to…
HPV vaccine coverage on the rise, but still far from 2020 goal
(Reuters Health) – The proportion of boys and young men in the U.S. receiving the human papillomavirus (HPV) vaccine has more than tripled since 2011, new research shows. Among 9-…
Starbucks must put cancer warning on California coffee: judge
(Reuters) – Starbucks Corp (SBUX.O) and other coffee companies must put a cancer warning label on coffee products sold in California, a Los Angeles judge ruled. FILE PHOTO – A…
African American Health Concerns
A Powerpoint presentation on the top health concerns for the African America Population. source
AbbVie’s lung cancer drug data disappoints; shares slump
(Reuters) – AbbVie Inc’s experimental lung cancer drug data was not effective enough to seek a faster approval, in a setback to the company’s efforts to build its cancer drug…